Journal Review

Nurse Survey Identifies Adverse Events Related to Handling Chemotherapy

Nurse Survey Identifies Adverse Events Related to Handling Chemotherapy

Using a 4-question survey, investigators determined oncology nurses' perception of their risks in handling and administering cytotoxic chemotherapy to patients.

No Benefit to Extensive Cancer Screening in Unprovoked Venous Thromboembolism

No Benefit to Extensive Cancer Screening in Unprovoked Venous Thromboembolism

Although unprovoked VTE may be a sign of occult cancer, results of a meta-analysis showed no benefit to extensive cancer screening in these patients.

Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes

Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes

As the use of checkpoint inhibitors increases in many types of cancer, oncology nurses need to learn to recognize the signs and symptoms of pneumonitis, a rare but life-threatening adverse effect of these agents.

Pain Management, Cancer Care at End-of-Life Improved by Caregiver Education, Training Intervention

Pain Management, Cancer Care at End-of-Life Improved by Caregiver Education, Training Intervention

Novel intervention focuses on caregivers' beliefs, knowledge, and skills regarding home care for patients with cancer resulting in improved pain management and better overall care at the end of life.

Mastectomy vs BCT: Understanding Women's Treatment Choice for Early-Stage Breast Cancer

Mastectomy vs BCT: Understanding Women's Treatment Choice for Early-Stage Breast Cancer

Canadian investigators sought to understand the factors that influence the treatment choices of women with early-stage breast cancer.

Rolapitant Eases CINV in Patients Receiving Highly, Moderately Emetogenic Chemotherapy

Rolapitant Eases CINV in Patients Receiving Highly, Moderately Emetogenic Chemotherapy

Long-acting NK-1 receptor antagonist rolapitant demonstrates significant efficacy in managing CINV in patients receiving HEC or MEC for cancer.

Optimal Management of Myeloma With Bortezomib

Optimal Management of Myeloma With Bortezomib

In this review of the role of bortezomib in the treatment of multiple myeloma, the researchers explain what nurses need to watch for in patients taking this drug.

Role of Oncology Nurse Navigators Has Evolved and Expanded in 5 Years

Role of Oncology Nurse Navigators Has Evolved and Expanded in 5 Years

Oncology Nursing Society conducted a role delineation survey (RDS) on oncology nurse navigators (ONNs) to determine how the role has evolved since the previous RDS and to determine if an ONN certification is needed.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs